Navigation Links
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Date:10/22/2007

to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward- looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACT: Paul Donovan

508-650-8541 (office)

508-667-5165 (mobile)

Media Relations

Boston Scientific Corporation

Dan Brennan

508-650-8538 (office)

617-459-2703 (mobile)

Investor Relations

Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
4. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
5. To Stent or Not: Is That the Question?
6. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Efficacy of OrbusNeichs Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
9. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
11. Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Fenwal Inc., a global leader ... patient care, reiterated its commitment to provide blood centers ... products, despite a new lawsuit filed yesterday against Fenwal ... system, introduced in 2003, is an advanced medical instrument ... from a single donor in about 30 minutes. ...
(Date:12/15/2009)... Pa., Dec. 15 West Pharmaceutical Services, Inc. ... Board of Directors has approved payment of the first-quarter ... will be paid on February 3, 2010 to shareholders ... About West ,, West is a global manufacturer ... stoppers and seals for vials, and closures and disposable ...
(Date:12/15/2009)... MONICA, Calif., Dec. 15 Dakim, Inc. and ... Thanks for Loved Ones, Brain Health Contest, designed to ... symptoms of dementia and Alzheimer,s disease. All five winners ... product designed specifically to help seniors preserve their brain ... kind in senior living communities across the country. ...
Breaking Medicine Technology:Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 35 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Protein level may serve as predictor of severe osteoarthritis 53174 1Protein level may serve as predictor of severe osteoarthritis 53174 2Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 1Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 2Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 3A crystal ball for brain cancer 3F 9422 1A crystal ball for brain cancer 3F 9422 2A crystal ball for brain cancer 3F 9422 3
(Date:12/16/2009)... have myopia now than in the ,70s, study finds ... is more common in the United States than it ... Institute study shows. , Researchers compared National Health and ... participants from 1971 to 1972 and from 8,339 black ... were 12 to 54 years old. , The prevalence ...
(Date:12/16/2009)... week trial bottle sample with purchase of 90-count bottle. , ... ... ImmuneResponse247.com announces a special free offer for a “Free ... Mushroom Formula , with the purchase of a 90-count bottle. ... packaged in FDA approved facilities and blends the 6 most important ...
(Date:12/16/2009)... to announce being presented with the Weatherhead 100 Upstart Award on ... companies in Northeast Ohio and is a testament to hard work, ... , ... (PRWEB) December 16, 2009 -- Request A Test, ... Upstart Award on December 3, 2009. The Weatherhead 100 showcases ...
(Date:12/16/2009)... are rapidly approaching and what would be the perfect gift to ... of course! Celebrity Beauty Engineer® and Licensed Esthetician Mary Schook introduces ... look and feel their best! , ... (PRWEB) December ... of gift does a person get that special woman who has ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate ... and Affordable Care Act that would have helped ... the safe and legal importation of lower priced ... AARP and sponsored by Senators Dorgan, Snowe, McCain, ... helped to bring down the skyrocketing costs of ...
Breaking Medicine News(10 mins):Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3
... pharmaceutical packaging customers new microfilling capabilities for pouches, ... maximum job flexibility and productivity, the Clifton, NJ ... schedule for packaging solid dose preparations, liquids and ... packages, pouches, bottles and cans. , ...
... 10 The growing asthma & allergy friendly(TM) ... and adopted a certification standard and testing protocol ... allergy friendly(TM) Certification Program administered by the Asthma ... with the international research organization, Allergy Standards Limited ...
... The ABLE TO CHOOSE public awareness campaign, www.abletochoose.org ... opinion on people with disabilities, will officially launch February ... ABLE TO CHOOSE campaign invites Virginians to join in ... to people with disabilities," said Heidi Lawyer, Executive Director ...
... With the rising cost of health care, more and ... cost-effective care. During National Wise Health Consumer Month ... to take another look at chiropractic care.February is ... excellent time for Minnesotans to learn about chiropractic care ...
... Freedom (IHF) is warning the public that the economic ... each American to use "an" electronic health record (EHR) ... to add opt-out and patient-consent provisions to ensure true ... line is that if YOU want to control the ...
... - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: ... on Wednesday, February 11, 2009 at 4:30 P.M. EST to ... Cruz, Chairman and Chief Executive Officer of the Company, will ... this period in a press release to be issued prior ...
Other Medicine News:Health News:Compass Pharma Services Offers Microfill Capabilities to Contract Pharmaceutical Packaging Customers 2Health News:Helping to Clear the Air for Consumers - New Certification Standard for HEPA Filters Will Help Millions of People Make More Educated Choices 2Health News:Official Launch of ABLE TO CHOOSE Public Awareness Campaign 2Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 2Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 3Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 4Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 5Health News:Economic Stimulus Bill Mandates Electronic Health Records for Every American by 2014 - With No Opt-out Provision 2Health News:Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2009 Financial Results on Wednesday, February 11th, at 4:30 P.M. EST 2
ELX50 is a self-contained, user programmable, universal microstrip washer. The ELX50 can be used to wash assays including ELISA, Fluorescence, Chemolumineszenz, RIA, DNA probes and cellular assays....
Fully automatic NRTL and CE certified microplate reader....
Diareader ELX800G...
Elisa strip reader...
Medicine Products: